Satellos Bioscience Inc. of TORONTO, A6, a company, filed a Form D amendment with the SEC on 2009-12-01. The offering totals $3.3M, of which $3.3M was reported sold. Industry: Pharmaceuticals.
Showing 25 of 46 people.
| Name | Role | Location |
|---|---|---|
| John John Clement | Director | Vancouver, A1 |
| John John Clement | Executive Officer | Vancouver, A1 |
| Franklin D Berger | Director | Toronto, A6 |
| Frank Gleeson | Director | Toronto, A6 |
| Frank Gleeson | Executive Officer | Toronto, A6 |
| Frank Gleeson | Promoter | Toronto, A6 |
| Michael Robert Cross | Executive Officer | Toronto, A6 |
| William McVicar | Director | Toronto, A6 |
| Brian Bloom | Director | Toronto, A6 |
| Elizabeth Williams | Executive Officer | Croton on Hudson, NY |
| Stephanie D Brown | Director | Toronto, A6 |
| Michael Rudnicki | Executive Officer | Toronto, A6 |
| Michael Rudnicki | Promoter | Toronto, A6 |
| Bill Jarosz | Director | Toronto, A6 |
| Adam Mostafa | Director | Toronto, A6 |
| Philip D Lambert | Executive Officer | Toronto, A6 |
| Courtney D Wells | Executive Officer | Toronto, A6 |
| Geoff MacKay | Director | Toronto, A6 |
| Rima Al-awar | Director | Toronto, A6 |
| Michael Liggett | Director | Vancouver, A1 |
| Michael Liggett | Executive Officer | Vancouver, A1 |
| J. Robert Hall | Executive Officer | Toronto, A6 |
| Warren Whitehead | Executive Officer | Toronto, A6 |
| SUSAN KOPPY | Director | VANCOUVER, A1 |
| ANDREW RAE | Director | VANCOUVER, A1 |
| Filed | Form | Offering | Sold |
|---|---|---|---|
| 2025-01-03 | D | $25.0M | $25.0M |
| 2023-05-25 | D | $33.3M | $33.3M |
| 2022-09-27 | D | $2.1M | $99K |
| 2019-09-10 | D | $2.5M | $188K |
| 2019-03-08 | D | $972K | $152K |
| 2014-02-05 | D | $7.9M | $2.0M |
| 2013-11-21 | D/A | $126K | $126K |
| 2011-11-15 | D | $50K | $50K |
| 2009-11-06 | D | $2.7M | $2.7M |